| NCT ID | NCT05521451 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitätsklinikum Hamburg-Eppendorf |
| Condition | Arrhythmias, Cardiac |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2021-03-17 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2021-03-17 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The "Long-term Outcome and Predictors for Recurrence after Medical and Interventional Treatment of Arrhythmias at the University Heart Center Hamburg" (TRUST) study is an investor-initiated, single-center, prospective clinical cohort study including patients treated with cardiac arrhythmias or at high risk for cardiac arrhythmias. The design enables prospective, low-threshold, near complete inclusion of patients with arrhythmias treated at the UHZ. Collection of routine follow-up data, detailed procedural information and systematic biobanking will enable precise and robust phenotyping.
Eligibility Criteria
Inclusion Criteria: * Cardiac arrhythmia, including congenital cardiac arrhythmia diagnosed at baseline or high risk for cardiac arrhythmia * Age ≥ 18 years * Written informed consent * Ability to provide written informed consent in accordance with Good Clinical Practice and local legislation Exclusion Criteria: * Insufficient knowledge of the German language to understand study documents and interview without translation * Physical or psychological incapability to cooperate in the investigation
Contact & Investigator
Paulus Kirchhof, MD
PRINCIPAL INVESTIGATOR
Universitätsklinikum Hamburg-Eppendorf
Frequently Asked Questions
Who can join the NCT05521451 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Arrhythmias, Cardiac. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05521451 currently recruiting?
Yes, NCT05521451 is actively recruiting participants. Contact the research team at trust@uke.de for enrollment information.
Where is the NCT05521451 trial being conducted?
This trial is being conducted at Hamburg, Germany.
Who is sponsoring the NCT05521451 clinical trial?
NCT05521451 is sponsored by Universitätsklinikum Hamburg-Eppendorf. The principal investigator is Paulus Kirchhof, MD at Universitätsklinikum Hamburg-Eppendorf. The trial plans to enroll 5,000 participants.